ai3Bio
PrivateLast Round
Series A
Sep 29, 2026
Total Funding Raised
$48M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ai3Bio is a biotechnology company that develops therapeutic platforms to treat autoimmune diseases by precisely targeting and eliminating disease-causing Th17 cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ai3Bio Comparables
Compare ai3Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera Therapeutics | 80% | |
| COUR Pharmaceuticals | 77% | |
| Cartesian Therapeutics | 76% |
ai3Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 29, 2026 |
ai3Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cockrell Interests | Series A |
| Ziff Capital Partners | Series A |
| Tanis Ventures | Series A |
| UPMC Enterprises | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2026
$48M round led by UPMC Enterprises and Ziff Capital Partners.
Recent news
Latest coverage and updates
- receives_financingSep 29, 2026
ai3 launches with $48M Series A funding on Sep 29th '26
ai3Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ai3Bio's valuation, stock price, and market status.
Is ai3Bio a public or private company?
ai3Bio is a private company.
What is the current stock price of ai3Bio?
ai3Bio is a private company with no public stock price. Caplight tracks ai3Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is ai3Bio worth (valuation)?
Valuation information for ai3Bio is not publicly available.
Can I buy ai3Bio stock?
ai3Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ai3Bio's last funding round?
ai3Bio's most recent funding round was Series A on September 29, 2026.
Who are the main investors in ai3Bio?
Key investors in ai3Bio include Ziff Capital Partners, UPMC Enterprises.
Will ai3Bio IPO soon?
No public IPO plans have been announced for ai3Bio.
How can I track ai3Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ai3Bio's secondary market activity and sign up for updates.